Smartleaf Asset Management’s Astrana Health ASTH Stock Holding History

Smartleaf Asset Management’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.75K	Sell	195 -333	-63%	-$7.88K	﹤0.01%	2678
2025 Q4	$13.2K	Sell	528 -47	-8%	-$1.25K	﹤0.01%	2257
2025 Q3	$16.7K	Buy	575 +136	+31%	+$3.69K	﹤0.01%	1880
2025 Q2	$10.9K	Sell	439 -28	-6%	-$789	﹤0.01%	1806
2025 Q1	$14.3K	Sell	467 -172	-27%	-$5.73K	﹤0.01%	1777
2024 Q4	$20.4K	Buy	639 +485	+315%	+$23K	﹤0.01%	1626
2024 Q3	$8.71K	Buy	154 +40	+35%	+$1.97K	﹤0.01%	1842
2024 Q2	$4.65K	Buy	114 +24	+27%	+$952	﹤0.01%	1845
2024 Q1	$3.7K	Buy	+90	New	+$3.51K	﹤0.01%	1318

Other funds holding ASTH

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return